PS Ratio
N/A
75 min ago
Summary
- DNLI price to sales ratio is not available.
Performance
DNLI PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
DNLI PS Ratio Trends
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | - | +0.4% | +0.4% | - |
| 1 m1 month | - | +5.0% | +5.0% | - |
| 3 m3 months | - | -24.8% | -24.8% | - |
| 6 m6 months | - | +2.6% | +3.2% | - |
| ytdytd | - | +9.2% | +9.2% | - |
| 1 y1 year | - | +30.8% | +36.0% | - |
| 5 y5 years | - | -11.3% | +21.5% | - |
DNLI PS Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | ||||
| 3 m | 3-month | ||||
| 6 m | 6-month | ||||
| 1 y | 1-year | ||||
| 3 y | 3-year | 96.37 | 6.44 | ||
| 5 y | 5-year | 477.10 | 6.44 | ||
| alltime | all time | 3096.99 | 6.44 |
Denali Therapeutics PS Ratio History
| Date | Value |
|---|---|
| 2022 | 34.86(-68.9%) |
| 2021 | 112.08(+272.6%) |
| Date | Value |
|---|---|
| 2020 | 30.08(-52.1%) |
| 2019 | 62.81(+314.9%) |
| 2018 | 15.14 |
FAQ
- What is the all time high PS ratio for Denali Therapeutics?
What is the all time high PS ratio for Denali Therapeutics?
Denali Therapeutics all-time high price to sales ratio is 3096.99